Annie Shin

Title: Innovations and Contributions of Inventor Annie Shin

Introduction

Annie Shin is a prominent inventor based in Culver City, California. She has made significant contributions to the field of biotechnology, particularly in the development of vaccines and RNA production systems. With a total of six patents to her name, her work has the potential to impact public health and therapeutic strategies.

Latest Patents

Annie Shin's latest patents include an enzyme-based system for the production of messenger RNA with increased transfection efficiency. This method focuses on producing proteins used in the in vitro transcription of mRNA, ensuring that the proteins are evaluated for purity and efficacy based on their ability to transfect cells and produce encoded proteins. Another notable patent involves SARS-CoV-2 vaccines that utilize human adenovirus vectors encoding spike and nucleocapsid immunogens. This patent outlines methods for inducing immunity against coronaviruses in mucosal tissues through various administration routes, including oral and nasal methods. Additionally, it presents compositions for assaying the presence of anti-viral antibodies and viral proteins in saliva samples.

Career Highlights

Annie has worked with several innovative companies, including NantBio, Inc. and ImmunityBio, Inc. Her experience in these organizations has allowed her to collaborate on groundbreaking research and development projects that address critical health challenges.

Collaborations

Annie has collaborated with notable professionals in her field, including Kayvan R. Niazi and Wael Tadros. These partnerships have contributed to her success and the advancement of her research initiatives.

Conclusion

Annie Shin's contributions to biotechnology and her innovative patents highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in vaccine development and RNA technology.